Expected Results

1. Environmental

  • Discharge prevention to wastewater for about 10 m3 per day (3650 m3/year) of wastewater contaminated with traces of antibiotics that may contribute to the development of antimicrobial resistance.
  • 1,606 kg of APIs will be converted to nontoxic compounds before being discharged in the wastewater sewage system per year.
  • Elimination of environmental impacts occurring due to poor controlled discharge of APIs in the wastewater sewage system.
  • Minimize the environmental footprint of the system using 100% renewable energy sources.

2. Policy

  • Policy recommendations in the EU, due to relevant results of the project, for treatment of wastewater effluent containing traces of APIs (Active Pharmaceutical Ingredients).

3. Exploitation

  • Further development of a new, innovative method for the detoxification of APIs and upscaling of the method from the lab/pilot scale to the industrial scale for the treatment of pharmaceutical industry wastewater.
  • Demonstrate a novel technology for the treatment of pharmaceutical wastewater, which will fully exploit (operate with) renewable energy (solar).

4. Socio-economic

    • Use of an economically viable, cost-effective method for the detoxification of pharmaceutical substances in a pharmaceutical facility wastewater.
    • Communication and promotion of public awareness at local and regional level, authorities, universities and pharmaceutical manufacturing industries.